A Canadian real-world study to evluate the efficacy and safety of ENTYVIO in biologic-naïve, adult patients with ulcerative colitis (UC) or Crohn's disease (CD).
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Vedolizumab
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 21 Feb 2018 New trial record
- 20 Feb 2018 According to a Takeda media release, interim results were presented at at the 13th Congress of the European Crohns and Colitis Organization (ECCO).